Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

March 3, 2022

Study Completion Date

March 3, 2022

Conditions
Breast Cancer
Interventions
RADIATION

Tomotherapy

"Dose prescription:~Whole breast irradiation: 25 Gy in 5 daily fractions of 5 Gy Boost: 30 Gy in 5 daily fractions of 6 Gy The boost will be delivered as a simultaneous integrated boost (SIB).~Target volumes:~Clinical target volume (CTV) breast: defined by the soft tissue of the breast down to the pectoralis fascia, but excluding the skin and the underlying muscle, ribs, lung and heart.~Gross tumor volume (GTV) boost: includes all gross tumor volume, as visible on computer tomography, mammography and/or magnetic resonance imaging (MRI). MRI imaging is preferentially performed in treatment position.~CTV boost: includes the primary tumor, with a margin of 1.0 cm in all directions to encompass potential microscopic disease extension. The CTV boost excludes the skin, pectoralis muscle, ribs, lung and heart.~Planning target volume (PTV): CTV plus a margin of 5 mm in all directions, but limited at 5 mm below the skin surface."

Trial Locations (3)

1020

CHU Brugmann, Brussels

1090

UZ Brussel, Brussels

9200

AZ Sint Blasius, Dendermonde

All Listed Sponsors
lead

Andre Nazac

OTHER

NCT02858934 - Feasibility Study of Accelerated Preoperative Radiotherapy for Early Breast Cancer | Biotech Hunter | Biotech Hunter